Year |
Citation |
Score |
2012 |
Kummer NT, Nowicki TS, Azzi JP, Reyes I, Iacob C, Xie S, Swati I, Darzynkiewicz Z, Gotlinger KH, Suslina N, Schantz S, Tiwari RK, Geliebter J. Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction. Journal of Cellular Biochemistry. 113: 1998-2008. PMID 22253131 DOI: 10.1002/Jcb.24069 |
0.638 |
|
2011 |
Nowicki TS, Moscatello AL, Shin E, Schantz S, Tiwari RK, Geliebter J. The urokinase plasminogen activator system in metastatic papillary thyroid carcinoma: a potential therapeutic target. The Journal of Clinical Endocrinology and Metabolism. 96: 3062-4. PMID 21832115 DOI: 10.1210/Jc.2011-1123 |
0.672 |
|
2011 |
Nowicki TS, Zhao H, Darzynkiewicz Z, Moscatello A, Shin E, Schantz S, Tiwari RK, Geliebter J. Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells. Cell Cycle (Georgetown, Tex.). 10: 100-7. PMID 21191179 DOI: 10.4161/Cc.10.1.14362 |
0.686 |
|
2011 |
MacEwan M, Mehta V, Darr EA, Xie S, Nowicki TS, Iacob C, Suslina N, Reyes I, Schantz S, Shin E, Tiwari R, Geliebter J. Abstract 1502: Increased expression of KLK7 and KLK10 in papillary thyroid cancer Cancer Research. 71: 1502-1502. DOI: 10.1158/1538-7445.Am2011-1502 |
0.689 |
|
2011 |
Nowicki TS, Zhao H, Darzynkiewicz Z, Moscatello A, Schantz S, Shin E, Tiwari RK, Geliebter J. Abstract 1406: Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling, and induces senescence in papillary thyroid carcinoma cells Cancer Research. 71: 1406-1406. DOI: 10.1158/1538-7445.Am2011-1406 |
0.681 |
|
2011 |
Darr EA, Nowicki TS, Kummer N, MacEwan M, Dunbar J, Suslina N, Iacob C, Shin E, Schantz S, Tiwari R, Geliebter J. Abstract 1063: BRAFV600Estatus predicts higher uPA levels in papillary thyroid cancer Cancer Research. 71: 1063-1063. DOI: 10.1158/1538-7445.Am2011-1063 |
0.68 |
|
2011 |
Ashlie Darr E, Nowicki TS, MacEwan ME, Dunbar J, Iacob C, Geliebter J. BRAFV600E is associated with increased uPA levels in papillary thyroid cancer Laryngoscope. 121. DOI: 10.1002/Lary.22229 |
0.669 |
|
2010 |
Nowicki TS, Kummer NT, Iacob C, Suslina N, Schaefer S, Schantz S, Shin E, Moscatello AL, Tiwari RK, Geliebter J. Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells. The Laryngoscope. 120: 1383-90. PMID 20578104 DOI: 10.1002/Lary.20915 |
0.702 |
|
2010 |
Nowicki TS, Kummer NT, Iacob C, Suslina N, Moscatello A, Schantz S, Schaefer S, Shin E, Tiwari RK, Geliebter J. Abstract 520: Inhibition of uPAR and uPA reduces invasion and degradative potential in papillary thyroid carcinoma cells Cancer Research. 70: 520-520. DOI: 10.1158/1538-7445.Am10-520 |
0.698 |
|
2010 |
Mehta V, Cooke SL, Yu G, Nowicki TS, Geliebter J, Tran T, Persky MS. Increased estrogen and the risk of papillary thyroid cancer Laryngoscope. 120: S16. DOI: 10.1002/Lary.21194 |
0.637 |
|
Show low-probability matches. |